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PURPOSE. Corneal endothelial cell density undergoes a progressive decrease for many years
after transplantation, eventually threatening patients with late endothelial failure. The
purpose of this study was to investigate the possibility of an immunologic response in
successfully grafted corneal endothelium.
METHODS. The corneal endothelium of patients who had undergone corneal transplantation
was evaluated by specular microscopy. Rabbit models were subjected to penetrating
keratoplasty (PK) with either syngeneic or allogeneic corneal transplants and Descemet’s
stripping endothelial keratoplasty (DSEK) with allogeneic corneal transplants. The presence
of immune cells and expression of proinflammatory cytokines were determined by
immunostaining. The corneal endothelium and immune cells were also evaluated by
scanning electron microscopy.
RESULTS. Scanning slit contact specular microscopy of patients with no features of graft
rejection revealed cell-like white dots on the grafted corneal endothelium. The corneal
endothelium of the allogeneic PK and DSEK rabbit models displayed the presence of immune
cells, including CD4þ T-helper cells, CD8þ cytotoxic T cells, CD20þ B lymphocytes, CD68þ
macrophages, and neutrophils, but these immune cells were rarely observed in the syngeneic
PK model. These immune cells also produced proinflammatory cytokines. Notably, some of
the corneal endothelial cells situated near these immune cells exhibited features of apoptosis.
CONCLUSIONS. T lymphocytes, B lymphocytes, macrophages, and neutrophils are present on
the grafted corneal endothelium in both PK and DSEK allogeneic rabbit models. The potential
involvement of immune cells as an underlying pathophysiology for late endothelial failure
deserves further examination.
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Corneal transplantation is one of the most commontransplantations performed in the world.1 The Eye Bank
Association of America2 reported that 47,530 donor corneas
were provided for transplantation in the United States; similarly,
28,901 donor corneas were provided for transplantation in
other countries in 2014. Corneal transplantation has been
accepted as a successful procedure, but several large cohort
studies have now shown that graft survival after 10 years
following penetrating keratoplasty (PK) is only approximately
50%,3–5 although this varies widely depending on the indica-
tions and the specific studies.6,7 Endothelial dysfunction also
accounts for 50% of the total graft failures, suggesting that
corneal endothelial damage is the leading cause of graft
failure.5,7
Endothelial graft failure can be divided into three types:
primary graft failure (mainly iatrogenic), immunologic rejection,
and late endothelial failure.6 Graft rejection is clinically
recognized by features that include the presence of endothelial
rejection line, keratic precipitates, corneal edema, and conjunc-
tival injection caused by immunologic responses against donor
cells.8–10 One multicenter study revealed that 92 of 1090 patients
(8.4%) experienced graft failure within 5 years of follow-up due
to rejection after PK. On the other hand, late endothelial failure
typically exhibits no clinical symptoms, but several studies,
including a large cohort study based on graft registries, have
demonstrated that corneal endothelial cell (CEC) density
decreases continuously, even in clinically successful transplanta-
tion cases. For instance, the Cornea Donor Study Research
Group reported that patients who underwent PK experienced a
cell loss of 79%, resulting in a median 10-year corneal endothelial
cell density (ECD) of 550 cells/mm2.7
The damage to the corneal endothelium associated with
ECD drop is compensated by increased pump function and
barrier function by remaining CECs, which maintains corneal
transparency.11 However, a decrease in the ECD to a critical
level, typically 500 cells/mm2, overwhelms this ability to
compensate, and the cornea begins to exhibit corneal edema
with severe visual disturbance. This suggests that graft corneas,
on average, come close to the threshold ability to maintain
corneal transparency or exhibit haziness within a decade. Late
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endothelial failure is accepted as a leading threat of graft
failure, but the underlying mechanism remains unclear and no
treatment is available. Hence, a better understanding of the
source of this failure is urgently needed, not only for
understanding the pathophysiology, but also for developing
preventive treatments for late endothelial failure.
Birnbaum and colleagues12 reported that the relative annual
loss of endothelial cells was 1.1% after autologous rotational
keratoplasty, whereas the relative annual loss was 16.7% in
homologous PK.12 Only six patients were analyzed as the
autologous rotational keratoplasty group, but these authors
hypothesized that immunologic influences might be the cause
of the chronic endothelial cell loss observed after corneal
transplantation.12 We pursued this idea by investigating the
potential involvement of an immunologic response in the CECs
of corneal grafts that are clinically transparent without
rejection symptoms after transplantation.
In this study, we explored the possibility of an immunologic
response in the corneal endothelium in a rabbit corneal
transplantation model. We showed that immune cells, such as
CD4þ T-helper cells, CD8þ cytotoxic T cells, CD20þ B
lymphocytes, CD68þ macrophages and neutrophils, were
present on the corneal endothelium after allogeneic corneal
transplantation, whereas these immune cells were rarely
observed in syngeneic grafts. We also demonstrated that
proinflammatory cytokines, such as TNF-a and IFN-c, were
expressed by immune cells.
METHODS
Ethics Statement
All animals were housed and treated in strict accordance with
the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. All experiments were carried out under a
Doshisha University Animal Care and Use Committee approved
protocol (approval no. A15012), and all efforts were made to
ameliorate animal suffering.
Clinical Data
The human clinical data were obtained in accordance with the
tenets set forth in the Declaration of Helsinki and in accordance
with a protocol approved by the Institutional Review Board of
Kyoto Prefectural University of Medicine (approval no. RBMR-C-
1073-1). Clinical trial registration was obtained from the
University Hospital Medical Information Network (UMIN; ID:
UMIN000021264) (http://www.umin.ac.jp/english/, provided in
the public domain). The corneal endothelium was evaluated by
contact specular microscopy (Konan scanning slit specular
microscope; Konan Medical, Nishinomiya, Japan) at the follow-
up clinical observations of patients who had undergone corneal
transplantation at the Kyoto Prefectural University of Medicine.
Rabbit Penetrating Corneal Transplantation Model
Twenty-one eyes of 15 rabbits were grafted with either
syngeneic (n ¼ 12) or allogeneic (n ¼ 15) corneal transplants.
For syngeneic corneal transplantation, 8-mm-diameter corneal
buttons were trephined (Hessburg-Barron Vacuum Trephine;
Barron Precision Instruments, LLC, Grand Blanc, MI, USA),
stored in media (Optisol-GS; Bausch & Lomb, Inc., Rochester,
NY, USA), and transplanted back into the original eye using 10-0
nylon ophthalmic sutures (MANI Ophthalmic Sutures; MANI,
Inc., Utsunomiya, Japan). For allogeneic corneal transplantation,
8-mm-diameter corneal buttons were trephined with a trephine,
stored in media (Optisol-GS; Bausch & Lomb, Inc.) and
transplanted into a different rabbit eye. Following corneal
transplantation, 0.33-mg dexamethasone (Nichi-Iko Pharmaceu-
tical Co., Ltd., Toyama, Japan) was injected into the subcon-
junctiva for 1 week. Anterior segments were assessed with a slit-
lamp microscope. Corneal thickness and volume were evaluated
with a camera system (Pentacam; OCULUS Optikgera¨te GmbH,
Wetzlar, Germany). The corneal endothelium was evaluated by
contact specular microscopy (Konan scanning slit specular
microscope; Konan Medical) (n ¼ 6). After observation for 2
weeks, corneal specimens were evaluated by immunofluores-
cence stating. To analyze rejected specimens, three rabbits with
transplanted allogeneic grafts were observed for up to 2 months
and subjected to histologic experiments when graft rejection
was observed associated with clinical symptoms such as corneal
haziness, corneal edema, and conjunctival injection.
Rabbit Descemet’s Stripping Endothelial
Keratoplasty (DSEK) Model
For preparing DSEK graft, deep lamellar keratectomy was
performed in eight rabbit corneas using microkeratome (Moria
ALTK; MORIA, Inc., Doylestown, PA, USA), and the residual
corneal bed was trephined with an 8-mm-diameter dermal
punch (Dermapunch; Maruho Co., Ltd., Osaka, Japan). In
recipient rabbits, lenses were removed using a series 20000
Legacy surgical system (Alcon, Inc., Fort Worth, TX, USA)
under general anesthesia to deepen the anterior chamber 1
week prior to DSEK. Under general anesthesia, Descemet’s
membrane was stripped from eight eyes of eight rabbits, DSEK
grafts were transplanted using the standard DSEK procedure
applied in clinical settings.1 One 0.33-mg dexamethasone dose
was instilled by subconjunctival injection for 1 week. After
observation for 2 weeks, corneal specimens were processed
for immunofluorescence staining and scanning electron
microscopy (n ¼ 6). Two samples were processed for
semiquantitative RT-PCR.
Immunofluorescence
Full-thickness corneal tissue was fixed in 4% paraformaldehyde
for 10 minutes at room temperature, followed by perfusion in
0.5% Triton X-100 (Wako Pure Chemical Industries, Ltd.,
Osaka, Japan) for 5 minutes at room temperature to increase
tissue permeability. Nonspecific binding was blocked using 2%
BSA or 2% goat serum for 1 hour at room temperature. The
corneal endothelium was stained with function-related mark-
ers: ZO-1 (1:200; Zymed Laboratories, South San Francisco, CA,
USA) and Naþ/Kþ-ATPase (1:200; Upstate Biotechnology, Lake
Placid, NY, USA). The presence of immune cells was
determined using primary antibodies against CD3 (pan T
lymphocyte, 1:100; Abcam, Cambridge, UK), CD4 (T-helper
cells, 1:100; R&D Biotechnology, Minneapolis, MN, USA), CD8
(cytotoxic T cells, 1:100: R&D Biotechnology), CD20 (B
lymphocytes, 1:100: Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA), CD68 (macrophages, 1:100; Santa Cruz
Biotechnology, Inc.), cathepsin G (neutrophils, 1:100; Abcam),
TNF-a (1:100, Abcam), and IFN-c (1:100, Abcam). The
secondary antibody was Alexa Fluor 488-conjugated goat anti-
mouse (Life Technologies, Carlsbad, CA, USA) or Alexa Fluor
594-conjugated goat anti-rabbit IgG (Life Technologies), used at
a 1:1000 dilution. Cell morphology was evaluated after actin
staining with a 1:400 dilution of Alexa Fluor 635-conjugated
phalloidin (Life Technologies). Nuclei were stained with 40,6-
diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlin-
game, CA, USA). The samples were observed by fluorescence
microscopy (model TCS SP2 AOBS; Leica Microsystems,
Wetzlar, Germany) or a confocal laser scanning electron
microscopy (LEICA TCS SP8 Multiphoton; Leica Microsystems).
Image J (http://imagej.nih.gov/ij/; provided in the public
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domain by the National Institutes of Health, Bethesda, MD,
USA) was used to create three-dimensional reconstructions.
Semiquantitative RT- PCR
Descemet’s membrane, with corneal endothelium that includ-
ed immune cells, was stripped from corneas of the DSEK rabbit
model. Descemet’s membrane stripped from healthy corneas
was used as control (n ¼ 2). Total RNA was isolated using a
purification kit (RNeasy Mini Kit; Qiagen, Hilden, Germany).
The quality of the RNA preparations was measured with a
spectrophotometer (NanoDrop; Thermo Fisher Scientific, Inc.,
Waltham, MA, USA).
Ribonucleic acid was amplified using a transcriptome
amplification kit (QuantiTect Whole Transcriptome Kit;
Qiagen, Hilden, Germany). Specific primers, listed in the
Table, were designed, and the cDNA was subjected to PCR.
The internal control for gene analysis was glyceraldehyde 3-
phosphate dehydrogenase (GAPDH). Polymerase chain reac-
tions were carried out using DNA polymerase (Extaq; Takara
Bio, Inc., Otsu, Japan). The PCR amplification program
consisted of denaturation at 948C for 30 seconds, 35 cycles
of annealing at 548C for 30 seconds, and elongation at 728C for
30 seconds. The PCR products were separated by electropho-
resis on 2% agarose gels and detected under ultraviolet
illumination after ethidium bromide staining.
Scanning Electron Microscopy
Corneal specimens were obtained from two syngeneic and two
allogeneic PK rabbit models and two DSEK rabbit models. The
specimens were washed in 0.1 M So¨rensen buffer, fixed with
2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M
So¨rensen buffer, and postfixed with 1% osmium tetroxide.
This was followed by three washes in buffer before being
dehydrated through an alcohol series and then transferred to
hexamethyldilizane (HMDS) for two 30-minute changes (Agar
Scientific, Stansted, Essex, UK). Samples were left overnight to
allow the HMDS to undergo sublimation. Samples were
mounted on cylinder stubs (Agar Scientific) sputter-coated
with gold and examined in a JEOL 5600 scanning electron
microscope (JEOL Ltd., Tokyo, Japan).
Statistical Analysis
Data are reported as means 6 SEM. Differences between data
sets were determined for statistical significance (P value) using
Student’s t-test.
RESULTS
Cell-like White Dots Were Observed on the
Endothelium of Patients Following Corneal
Transplantation
Representative images of a patient who underwent penetrating
keratoplasty 24 years previously showed the presence of cell-
like white dots on the corneal endothelium (Fig. 1A). Likewise,
a patient who had undergone DSEK 5 years previously also
showed the white dots (Fig. 1B). Similar white dots were
TABLE. Oligonucleotide Sequences for RT-PCR
Gene Sense Primer Antisense Primer Size, bp
IL-1RA 50 -GAAGTTGTGCCTGTCTTGTGTG-30 50-CCTCCTGGAAGTAGAACTTGGT-30 262
IL-1b 50 -TGTTGTCTGGCACGTATGAGCTG-30 50-CTTCTTCTTTGGGTAACGGTTGGG-30 227
IL-6 50 -CTGAAGAACATCCAACACCTGATC-30 50-CCTAACGCTCATCTTCCTAGTTTC-30 329
IL-8 50 -ACACTCCACACCTTTCCATCC-30 50-CCTACGACAGATCCATGCAGT-30 293
IL-10 50 -CCCGATCCTATTTATTTACCGAGC-30 50-GTTAGAAAGTGTGGTCAGGCACAG-30 232
IL-15 50 -CTGTATCAGTGCAGGTCTTCC-30 50-CCTCCAGTTCCTCACATTCTTTGC-30 310
TNF-a 50 -CTCCCAGGTTCTCTTCAGCGGTC-30 50-GTCCAGGTACTCAGGCTGGTTGA -30 250
TGF-b2 50 -GATCTCCATCTACAACAGCACCAG-30 50-CTGAAGTAGGGTCTGTAGAAGGTG-30 266
CX3CR 50 -TGGCCGCCAACTCCATTAAC-30 50-GATGGCTTTGGCTTTCTTGTGG-30 292
CCL2 50 -CACCTGCTGCTATACATTCACC-30 50-GTCGTGTGTTCTTGGGTTGTG-30 236
CCL4 50 -CAGGAGTACGTGGATGACTTG-30 50-CAACAGCAGAGAAACAGTGGT-30 263
TLR4 50 -CTAACCTGTCTAGCCTTGAGCAC-30 50-CCACTCAGCCCTTGAATACAG-30 240
TRAIL 50 -CTGATCCTGATCTTCACAGTGCTCC30 50-CTACTCTCTGAGGCCCTCTTTCTC-30 328
GAPDH 50 -GCGTGAACCACGAGAAGTATGACAAC-30 50-CAGTGGAGGCAGGGATGATGTTC-30 234
bp indicates base pairs.
FIGURE 1. Cell-like white dots on the endothelium of patients following corneal transplantation. (A) Corneal endothelium was evaluated by contact
specular microscopy in patients who had undergone corneal transplantation. Representative image of a 36-year-old male who underwent PK 24
years previously shows the presence of cell-like white dots on the corneal endothelium. (B) Image from a 67-year-old female who underwent DSEK
5 years previously, showing the cell-like white dots. (C) Image of a 70-year-old male who was diagnosed with CMV corneal endotheliitis infection,
showing the cell-like white dots. Arrowheads indicate the cell-like white dots.
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observed on the corneal endothelium of a patient who was
diagnosed with cytomegalovirus (CMV) corneal endotheliitis,
which is an inflammatory disease due to CMV,13,14 suggesting
that the white dots were immune cells recruited due to an
immune response (Fig. 1C).
Allogeneic Corneal Transplantation Recruits
Immune Cells in Rabbit Model
We used a rabbit PK model to determine whether the white
dots observed on corneal endothelium were immune cells. Slit-
lamp microscopy showed that a transparent corneal graft was
maintained at 2 weeks postoperatively in both syngeneic and
allogeneic groups (Fig. 2A). No clinical features of corneal
allograft rejection, such as endothelial keratic precipitates,
rejection lines, or severe conjunctival injection were observed
in allogeneic or syngeneic grafts during the observation time of
2 weeks. Scheimpflug images and corneal thickness maps
obtained with a Pentacam high-resolution camera also showed
that an anatomically normal cornea had been restored by
corneal transplantation (Figs. 2B, 2C). No significant difference
was noted in the central corneal thickness and corneal volume
between the syngeneic and allogeneic groups (Figs. 2D, 2E).
The endothelial phenotype of the CECs in the syngeneic and
allogeneic corneal grafts was retained, along with expression
of function-related markers, such as ZO-1 (marker of barrier
function) and Naþ/Kþ-ATPase (marker of pump function), and
the hexagonal monolayer morphology (Fig. 2F). Contact
specular microscopy examination showed healthy morphology
of corneal endothelium in both syngeneic and allogeneic
groups 14 days after corneal transplantation. However, cell-like
white dots that were similar to the dots observed in human
subjects following corneal transplantation were observed on
corneal endothelium in the allogeneic group (Fig. 3A).
Scanning electron microscope analysis revealed the normal
hexagonal morphology of the corneal endothelium in both the
graft and peripheral recipient cornea in the syngeneic model as
well as in control corneas. However, scanning electron
microscope analysis revealed the presence of numerous cells
that were well distinguished from the corneal endothelium on
the surface of the allogeneic graft endothelium, and to a
significantly lesser extent, on the recipient corneal endotheli-
um. Notably, very few of these cells were observed in the
syngeneic group, but massive numbers of cells were observed
in the allogeneic group. Cell–cell junctions were partially
disrupted, and membrane blebbing, presumably associated
with the apoptotic process, was observed in nearby cells in the
corneal endothelium (Fig. 3B). Taken together, these findings
supported our hypothesis that the cell-like white dots were
immune cells that might be exerting potentially deleterious
effects on the corneal endothelium.
T-Helper Cells, Cytotoxic T Cells, B Lymphocytes,
Macrophages, and Neutrophils Infiltrate the
Corneal Endothelium of Allogeneic Corneal Grafts
We conducted an immunohistochemical analysis to character-
ize the infiltrated cells present on the corneal endothelium
FIGURE 2. Syngeneic and allogeneic PK rabbit model. (A) Represen-
tative anterior segment images (right: control healthy eye; middle:
syngeneic PK; and left: allogeneic PK) obtained by slit-lamp microsco-
py 14 days after transplantation are shown. (B, C) Anterior segment
was also evaluated. Representative images and corneal thickness maps
are shown. Values of the corneal thickness and corneal volume maps
are indicated in micrometers. (D, E) Central corneal thickness and
corneal volume were analyzed. No significant difference was noted in
the central corneal thickness and corneal volume between the
syngeneic and allogeneic transplantation groups. (F) Corneal endothe-
lial structure and function of the syngeneic and allogeneic grafts were
examined histologically 14 days after transplantation. Corneal endo-
thelial morphology was assessed by actin staining, and endothelial
function was assessed by immunostaining for ZO-1 and Naþ/Kþ-ATPase.
Cell nuclei were stained with DAPI. Representative images from at least
two independent experiments are shown. Scale bar: 100 lm.
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after allogeneic corneal transplantation in rabbits. None of the
grafts (syngeneic or allogeneic) displayed any clinical signs of
organ rejection, but immune cells, characterized by the
presence of CD4þ T-helper cells, CD8þ cytotoxic T cells,
CD20þ B lymphocytes, CD68þ macrophages, and neutrophils
marked by cathepsin G, were observed on the endothelial layer
in nine out of nine allogeneic graft specimens 2 weeks after
transplantation. Similar to the scanning electron microscope
findings, these immune cells were rarely observed in the
syngeneic grafts (Fig. 4A). As a positive control, where
infiltration of immune cells would be expected, we analyzed
corneal grafts that had been rejected 2 months after allogeneic
transplantation. All three rabbits that had been observed for 2
months exhibited signs associated with graft rejection, such as
corneal haziness, corneal edema, and conjunctival injection at
1.5 to 2 months. The rejected corneal grafts exhibited distinct
morphologic alterations as determined by the cellular distri-
bution of F-actin, which suggested CEC transformation into
fibroblast-like cells, as occurs in human corneal graft rejection.
Higher numbers of infiltrating immune cells—CD4þ T-helper
cells, CD8þ cytotoxic T cells, CD20þ B lymphocytes, CD68þ
macrophages, and neutrophils—were observed on the rejected
corneal endothelium than on the nonrejected allogeneic graft
(Fig. 4A).
Immune cells secrete cytokines that are critical regulators of
immune response; therefore, we investigated whether proin-
flammatory cytokines were secreted in corneal grafts. Tumor
necrosis factor-a and IFN-c were detectable in the allogeneic
graft endothelium, which showed no clinical features of
rejection 2 weeks after corneal transplantation, but TNF-a
and IFN-c were not detected in the syngeneic graft or the
control (Fig. 4B). Co-staining showed that a certain population
of CD4þ T-helper cells expressed TNF-a and IFN-c and that a
certain population of CD8þ cytotoxic T cells expressed TNF-a
and IFN-c in the allogeneic grafts 2 weeks after surgery (Fig.
4C).
Immune Cells Infiltrate on the Corneal
Endothelium of Allogeneic DSEK Graft
We next determined the infiltration of immune cells onto the
corneal endothelium of a DSEK graft, as the CEC declines seen
after transplantation of DSEK grafts are at the same level (or
even worse) as that seen in PK.6,15–17 Corneal transplantation
performed as a DSEK procedure in the rabbit gave a successful
graft in all cases, with a transparent cornea and no serious
complications such as graft rejection, graft failure, or graft
dislocation. Representative slit-lamp microscopic images
showed attachment of the graft to the back side of cornea,
and corneal transparency was maintained in the rabbit model 2
weeks after surgery (Fig. 5A). Scanning electron microscope
demonstrated the presence of numerous discrete nonendothe-
lial cells, morphologically similar to immune cells in appear-
ance, present near the graft–recipient interface (Fig. 5B).
Notably, a high density of immune-like cells was observed on
the corneal endothelium of the DSEK graft in contrast to the
recipient corneal endothelium, where very few immune-like
cells were found (Fig. 5C). The control eyes exhibited the
normal hexagonal morphology of the corneal endothelium
without any immune-like cells. Higher magnification scanning
electron microscope images showed that immune-like cells
were adjacent to a missing endothelial cell (Fig. 5D), suggesting
that these cells may have the ability to damage the corneal
endothelium.
FIGURE 3. Contact specular and scanning electron microscopy analysis of the corneal endothelium in the syngeneic and allogeneic corneal grafts.
(A) Corneal endothelial cell morphology was also assessed by contact specular microscopy, and representative images are shown for each
experimental group. In the allogeneic PK group, the corneal graft endothelium shows cell-like white dots, indicated by white arrowheads. (B)
Scanning electron microscope images of the corneal endothelium of a control healthy cornea, a syngeneic graft, and an allogeneic graft. Cell–cell
junctions were partially disrupted (arrows), and membrane blebbing (arrowheads) was observed near the immune cell–like cells on the corneal
endothelium of the allogeneic graft. All images are representative of two animals in each group. Scale bars: 5 lm.
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FIGURE 4. Immunofluorescence analysis of the corneal endothelium of the syngeneic and allogeneic PK model. (A) Control cornea, syngeneic
corneal graft, allogeneic corneal graft, and rejected allogeneic corneal graft were immunostained with CD4 (T-helper cells), CD8 (cytotoxic T cells),
CD20 (B cells), CD68 (macrophages), and cathepsin G (neutrophils) antibodies 14 days post transplantation. CD4þ T lymphocytes, CD8þ T
lymphocytes, CD20þ B lymphocytes, CD68þmacrophages, and neutrophils characterized the allogeneic PK graft endothelium layer and the rejected
graft cornea. DAPI was used to stain cell nuclei. Scale bar: 100 lm. (B) Secretion of TNF-a and IFN-c was determined in the control corneal
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Similar to the PK model, immunofluorescence analysis
demonstrated the presence of CD3þ T lymphocytes, CD4þ T-
helper cells, CD8þ cytotoxic T cells, CD20þ B lymphocytes,
and CD68þ macrophages on the corneal endothelium (Fig. 5E).
The recipient endothelium rarely showed the presence of
these immune cells, suggesting that the allogeneic corneal
endothelium has the ability to recruit immune cells. Consistent
with the findings observed previously for the PK corneal grafts,
TNF-a– and IFN-c–producing immune cells were also detected
in the DSEK graft endothelium (Fig. 5E). Image stacks of
specific depths and high resolution obtained by confocal laser
scanning electron microscopy of the DSEK corneas revealed
that these immune cells were attached onto the graft
endothelium layer positioned at the anterior chamber site
(Fig. 5F). The expression of cytokines related to inflammation
was evaluated 2 weeks after DSEK in corneal endothelium that
included immune cells. Semiquantitative RT-PCR showed
higher expression of IL-1 receptor antagonist (IL-1RA), IL-1b,
IL-6, IL-15, TNF-a, TGF-b2, CX3CR, and CCL2 in DSEK corneal
endothelium than in healthy corneal endothelium, while IL-8,
IL-10, TLR4, and TRAIL were detected at similar levels in both
groups (Fig. 5G).
DISCUSSION
The cornea is an immune-privileged tissue with properties that
prevent alloimmune-mediated rejection responses, which then
enables an advantageously high success rate of transplanta-
tion.18–24 Numerous basic research studies have demonstrated
that the immune privilege of the eye is not solely a
phenomenon due to immunologic ignorance, but instead is a
highly orchestrated immune system consisting of unique
immune suppression mechanisms, widely known as anterior
chamber–associated immune deviation.21–23,25 This immune-
privileged environment, as well as the underlying mechanisms
involved in corneal graft rejection by host immune systems,
has also been intensively investigated.22,26–29
By contrast, the mechanism of late endothelial failure is still
unclear. The clinical data showing the much lower drop in cell
density of CECs after autologous rotational corneal transplan-
tation than after allogeneic transplantation suggested the
possibility that immunologic influences are involved in the
pathogenesis of chronic endothelial failure.12 We showed that
cell-like white dots can be observed on the corneal endothe-
lium of a transplanted graft by scanning slit contact specular
microscopy in the patients who show no clinical features of
graft rejection. Similar cell-like white dots were also observed
on the corneal endothelium of the CMV corneal endotheliitis
patients, so we speculated that these dots might be immune
cells. In agreement with our findings, in vivo confocal
microscopy revealed the presence of indistinguishable small,
rounded white cell bodies representing inflammatory cell
structures on the corneal endothelium following corneal
transplantation.30,31 Our rabbit model experiments demon-
strated that the cell-like white dots observed by scanning slit
contact specular microscopy correspond to immune cells
comprising at least T-helper cells, cytotoxic T cells, B cells,
macrophages, and neutrophils. One limitation of our study is
that these cell-like white dots, revealed to be immune cells,
were observed 2 weeks after surgery in the rabbit model, but
they were observed in humans a longer time after the corneal
transplantation. Further investigation, such as using postmor-
tem corneal specimens in the patients, should determine
whether immune cells exist on the corneal endothelium of
patients who do not exhibit clinical features of graft rejection.
Another important question to be answered is whether this
immunologic response is induced owing to the surgical
intervention or to the allogeneic graft, as leukocyte extravasa-
tion and migration to injury sites are important milestones of
wound-healing process. Our histologic assessment demonstrat-
ed that immune cells were rarely observed on syngeneic grafts,
whereas they were intensively observed on allogeneic grafts.
This suggests that immune cells were recruited by allogeneic
grafts, though the nature of the signal—whether immune cells
recognized CECs or corneal stromal cells or did not recognize
allogeneic cells—should be further investigated. In agreement
with previous reports,26–29 rejected allogeneic grafts were
characterized by inflammatory cell aggregates composed of
CD4þ and CD8þ T lymphocytes, B lymphocytes, macrophages,
and neutrophils and by tissue destruction. Interestingly, unlike
the case for the rejected grafts, the cells observed in
transparent allogeneic grafts without clinical features of
rejection were not associated with destruction of the
surrounding CECs. One possible explanation for the presence
of immune cells on a nonrejected graft is that they have a
potency to precede typical graft rejection. Though this is
speculative, if the grafted cornea successfully evaded rejection
triggered by these immune cells, the graft would eventually
exhibit CEC loss. Graft rejection is typically observed after 2
months; therefore, analysis of animal models for a longer time
will help in understanding the role of these immune cells.
Another possible explanation is that the corneal endothelium
was damaged by an as yet unknown mechanism, and the
immune cells were recruited for a wound-healing process.
Further functional experiments to evaluate the cytotoxicity of
the adhered immune cells to the graft corneal endothelium are
needed to verify the role played by immune cells in corneal
endothelial damage.
Penetrating keratoplasty was previously the only procedure
for corneal transplantation, but new procedures, such as DSEK
and DMEK (Descemet’s membrane endothelial keratoplasty),
have been developed for replacement of the corneal endothe-
lium that do not involve full-thickness replacement.1 Stripping
endothelial keratoplasty and DMEK are less-invasive treatments
and are now frequently performed.32,33 Anshu et al.34 reported
rejection rates of 17% in PK, 9% in DSEK, and 0.7% in DMEK in
a single center and suggested that DSEK and DMEK reduced
the risk of rejection. This may be because DSEK and DMEK
grafts do not include epithelium, as each layer of the cornea
has different immunogenicity. Indeed, the use of reconstituted
mouse corneal grafts confirmed that the corneal epithelium
had a higher allosensitization potency when compared with
endothelium.35–37 By contrast, the incidence of graft rejection
in DSEK, and even in DMEK, suggests that the corneal
endothelium also has immunogenicity. Our current data for
our rabbit DSEK model showed that immune cells migrated
onto allogeneic graft corneal endothelium and expressed
proinflammatory cytokines, as observed in PK. We also
showed that the levels of cytokines related to inflammation
are higher in the DSEK corneal endothelium. However, the
source of these cytokines (i.e., the corneal endothelium or the
syngeneic corneal graft, allogeneic corneal graft, and rejected allogeneic corneal graft. Actin and cell nuclei were stained with generic term and
DAPI, respectively. All experiments were performed in duplicate. Scale bar: 100 lm. (C) Co-staining of CD4/TNF-a and IFN-c, and CD8/TNF-a and
IFN-c in allogeneic grafts 2 weeks after corneal transplantation. Nuclei were stained with DAPI. Experiments were performed on three independent
animals. Scale bar: 50 lm.
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FIGURE 5. Involvement of immune cells in the corneal endothelium of a DSEK graft. (A) Corneal transplantation was performed as a DSEK
procedure in six rabbits, and a representative slit-lamp microscopy image is shown. (B) Scanning electron microscopy evaluation of the donor–host
junction of the DSEK rabbit model. Scale bar: 500 lm. Higher magnification of the boxed area shown on the right-hand side. Scale bar: 100 lm. (C)
Scanning electron microscope demonstrated that numerous nonendothelial cells, morphologically with an immune cell–like appearance, were
present near the graft–recipient interface. A high density of these immune-like cells was observed on the corneal endothelium of the DSEK graft,
whereas the recipient corneal endothelium showed very few immune-like cells. The control eyes exhibited a hexagonal, normal morphologic
corneal endothelium without any immune-like cells. All images are representative of two animals in each group. Scale bar: 2 lm. (D) Higher
magnification scanning electron microscope image showing immune-like cells adjacent to a missing endothelial cell. Scale bar: 2 lm. (E) Corneal
endothelium of the DSEK graft immunostained with immune cell–related markers: CD4þ cell (T-helper cells), CD8þ cell (cytotoxic T cells), CD20þ
cell (B cells), and CD68þ cell (macrophages). Production of TNF-a and IFN-c was also evaluated by immunostaining. Actin and cell nuclei were
stained with Alexa Fluor 594–conjugated phalloidin and DAPI, respectively All experiments were performed in triplicate. Scale bar: 100 lm. (F)
Stripping endothelial keratoplasty corneas were analyzed by confocal laser scanning electron microscopy. Image stacks up to a depth of 150 lm, at
either 1- or 3-lm intervals, were acquired, and three-dimensional reconstructions were created. Representative still images for CD3þ T lymphocytes,
CD8þ T lymphocytes, and CD68þ macrophages on the corneal endothelium are shown. Actin staining was performed to evaluate cell morphology.
Nuclei were stained with DAPI. (G) The expression of cytokines related to inflammation was evaluated 2 weeks after DSEK in corneal endothelium
that included immune cells by semiquantitative RT-PCR.
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immune cells) was not established in the current study.
Nevertheless, the elevated cytokine levels might suggest an
involvement of immune cells as part of the underlying
mechanism of CEC loss in corneal endothelial transplantation
performed using procedures other than just conventional PK.
In conclusion, our data suggest that T lymphocytes, B
lymphocytes, macrophages, and neutrophils are present on the
grafted corneal endothelium following both PK and DSEK. The
current findings should stimulate further research aimed at
clearly elucidating the involvement of immune cells as an
underlying pathophysiology to provide treatment for late
endothelial failure.
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